Logo image of BIO

BIO-RAD LABORATORIES-A (BIO) Stock Analyst Earnings Estimates

NYSE:BIO - New York Stock Exchange, Inc. - US0905722072 - Common Stock - Currency: USD

276.8  -7.8 (-2.74%)

After market: 276.8 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
BIO revenue by date.BIO revenue by date.
2.802B
-4.12%
2.671B
-4.67%
2.567B
-3.92%
2.547B
-0.76%
2.634B
3.42%
2.745B
4.21%
2.725B
-0.73%
2.785B
2.20%
EBITDA
YoY % growth
BIO ebitda by date.BIO ebitda by date.
N/A
-13.40%
N/A
-19.14%
N/A
-8.95%
418.06M
-11.60%
462.84M
10.71%
502.06M
8.47%
434.43M
-13.47%
465.96M
7.26%
EBIT
YoY % growth
BIO ebit by date.BIO ebit by date.
486.8M
-13.79%
365.696M
-24.88%
298.5M
-18.37%
277.58M
-7.01%
322.52M
16.19%
360.18M
11.68%
531.26M
47.50%
N/A
Operating Margin
BIO operating margin by date.BIO operating margin by date.
17.37%13.69%11.63%10.90%12.24%13.12%19.50%N/A
EPS
YoY % growth
BIO eps by date.BIO eps by date.
14.23
-9.19%
11.77
-17.29%
10.31
-12.40%
8.52
-17.35%
9.37
9.95%
10.78
15.07%
8.21
-23.84%
8.26
0.62%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.84
-8.52%
2.82
-2.60%
2.42
-4.63%
3.04
16.48%
2.92
58.56%
3.19
12.88%
2.26
-6.60%
2.63
-13.62%
3.05
4.62%
3.65
14.36%
Revenue
Q2Q % growth
655.12M
0.83%
710.09M
6.38%
612.5M
4.63%
665.93M
2.20%
690.83M
5.45%
721.07M
1.55%
619.07M
1.07%
676.43M
1.58%
697.41M
0.95%
734.21M
1.82%
EBITDA
Q2Q % growth
98.549M
36.92%
132.88M
-0.78%
110M
31.03%
129.76M
36.80%
139.25M
41.30%
151.57M
14.07%
92.708M
-15.72%
123.41M
-4.89%
137.92M
-0.96%
159.19M
5.03%
EBIT
Q2Q % growth
63.661M
-32.28%
97.662M
67.43%
71.366M
25.42%
93.637M
17.78%
102.78M
61.45%
114.64M
17.38%
55.712M
-21.93%
86.587M
-7.53%
100.78M
-1.95%
121.51M
5.99%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
2.61
-16.08%
1.750.8649.07%
Q1 2025
Q2Q % growth
2.54
10.92%
1.830.7138.97%
Q4 2024
Q2Q % growth
2.90
-6.45%
2.900.000.10%
Q3 2024
Q2Q % growth
2.01
-13.73%
1.170.8472.05%
Q2 2024
Q2Q % growth
3.11
3.67%
2.031.0852.84%
Q1 2024
Q2Q % growth
2.29
-31.44%
2.170.125.67%
Q4 2023
Q2Q % growth
3.10
-6.34%
2.850.258.96%
Q3 2023
Q2Q % growth
2.33
-10.38%
2.81-0.48-17.09%
Q2 2023
Q2Q % growth
3.00
-11.24%
2.710.2910.88%
Q1 2023
Q2Q % growth
3.34
-32.39%
3.58-0.24-6.64%
Q4 2022
Q2Q % growth
3.31
3.12%
3.48-0.17-4.96%
Q3 2022
Q2Q % growth
2.60
-29.92%
2.81-0.21-7.47%
Q2 2022
Q2Q % growth
3.38
-4.52%
2.830.5519.58%
Q1 2022
Q2Q % growth
4.94
-5.18%
3.441.5043.76%
Q4 2021
Q2Q % growth
3.21
-19.95%
2.880.3311.49%
Q3 2021
Q2Q % growth
3.71
23.67%
2.461.2550.71%
Q2 2021
Q2Q % growth
3.54
119.88%
2.690.8531.54%
Q1 2021
Q2Q % growth
5.21
172.77%
3.032.1872.12%
Q4 2020
Q2Q % growth
4.01
72.84%
3.330.6820.49%
Q3 2020
Q2Q % growth
3.00
86.34%
1.821.1864.86%
Q2 2020
Q2Q % growth
1.61
8.05%
1.240.3730.31%
Q1 2020
Q2Q % growth
1.91
15.76%
1.580.3320.84%
Q4 2019
Q2Q % growth
2.32 2.47-0.15-6.05%
Q3 2019
Q2Q % growth
1.61 1.420.1913.46%
Q2 2019
Q2Q % growth
1.49 1.350.1410.51%
Q1 2019
Q2Q % growth
1.65 1.120.5347.84%
BIO Yearly EPS VS EstimatesBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
651.6M
2.06%
621.36M30.24M4.87%
Q1 2025
Q2Q % growth
585.4M
-4.16%
579M6.4M1.11%
Q4 2024
Q2Q % growth
667.5M
-2.01%
686.09M-18.59M-2.71%
Q3 2024
Q2Q % growth
649.729M
2.79%
634.46M15.269M2.41%
Q2 2024
Q2Q % growth
638.476M
-6.26%
652.25M-13.774M-2.11%
Q1 2024
Q2Q % growth
610.82M
-9.75%
625.28M-14.46M-2.31%
Q4 2023
Q2Q % growth
681.184M
-6.73%
691.94M-10.756M-1.55%
Q3 2023
Q2Q % growth
632.1M
-7.15%
696.46M-64.36M-9.24%
Q2 2023
Q2Q % growth
681.11M
-1.45%
704.94M-23.83M-3.38%
Q1 2023
Q2Q % growth
676.844M
-3.32%
696.73M-19.886M-2.85%
Q4 2022
Q2Q % growth
730.3M
-0.34%
749.67M-19.37M-2.58%
Q3 2022
Q2Q % growth
680.8M
-8.86%
686.74M-5.94M-0.86%
Q2 2022
Q2Q % growth
691.1M
-3.46%
689.45M1.65M0.24%
Q1 2022
Q2Q % growth
700.1M
-3.67%
681.85M18.25M2.68%
Q4 2021
Q2Q % growth
732.8M
-7.22%
739.3M-6.5M-0.88%
Q3 2021
Q2Q % growth
747M
15.40%
668.49M78.51M11.74%
Q2 2021
Q2Q % growth
715.9M
33.34%
638.1M77.8M12.19%
Q1 2021
Q2Q % growth
726.8M
27.15%
667.59M59.21M8.87%
Q4 2020
Q2Q % growth
789.8M
26.49%
693.67M96.13M13.86%
Q3 2020
Q2Q % growth
647.3M
15.47%
576.28M71.02M12.32%
Q2 2020
Q2Q % growth
536.9M
-6.23%
522.22M14.68M2.81%
Q1 2020
Q2Q % growth
571.6M
3.18%
552.32M19.28M3.49%
Q4 2019
Q2Q % growth
624.4M 648.37M-23.97M-3.70%
Q3 2019
Q2Q % growth
560.6M 570.69M-10.09M-1.77%
Q2 2019
Q2Q % growth
572.6M 571.86M740K0.13%
Q1 2019
Q2Q % growth
554M 555.05M-1.05M-0.19%
BIO Yearly Revenue VS EstimatesBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.25% -30.61% -1.39% -12.45%
Revenue0.02% -3.11% 0% -1.58%